<DOC>
	<DOCNO>NCT01147432</DOCNO>
	<brief_summary>Prior administer PF-04427429 patient wish increase understand functional effect associate calcitonin gene relate peptide ( CGRP ) pathways . This study examine whether possible single dose PF-04427429 acutely attenuate capsaicin induce flare response .</brief_summary>
	<brief_title>Acute Response Capsaicin Flare Study</brief_title>
	<detailed_description>Proof mechanism healthy volunteer</detailed_description>
	<mesh_term>Capsaicin</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<criteria>Healthy male subject age 18 50 year inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . Skintype IIII distance base scaphoid antecubital fossa &gt; 26cm forearm . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , genitourinary , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , symptomatic , seasonal allergy time dose ) . Use biologics include live vaccine within 3 month prior screen prior treatment antibody previous clinical trial treatment immunoglobulin past 6 month . 12lead ECG demonstrate QTcF &gt; 450 msec screening . Subjects scars tattoo forearm , evidence sunburn , excessive hairy volar forearm .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Healthy male volunteer</keyword>
	<keyword>capsaicin challenge</keyword>
	<keyword>safety</keyword>
	<keyword>toleration</keyword>
</DOC>